About this event

  • Date and time Wed 10 Oct 2018 from 8:30am to 5:10pm
  • Location Royal Society of Medicine
  • Organised by Nephrology

Attend this conference to hear updated key developments in acute kidney injury (AKI).

There will be a keen focus on current research, best practice, new treatments, prevention and identification, and quality improvement, but will cover much more.

This conference will bring together investigators and experts from across the globe to discuss ongoing research and future strategies in acute kidney injury (AKI).

Topics include:

  • Review current research and best management in the field of acute kidney injuries in adults
  • The pathophysiology of AKI
  • New potential treatments for AKI
  • The prevention and identification of AKI in children

Key speakers

Dr Bruce Molitoris

Professor of Medicine and past President of the American Society of Nephrology, Indiana University School of Medicine, USA
Dr Molitoris will explore the pathophysiology of AKI

Dr Stuart Goldstein

Director, Center for Acute Care Nephrology, Cincinnati Children’s Hospital Medical Center, USA

Dr Goldstein will present his work on identifying and preventing AKI in paediatric patients

Dr Mitchell Rosner

Professor and Chair of Medicine, University of Virginia, USA

Dr Rosner will present his work on a comprehensive update on new therapies in AKI 

Professor Neil Sheerin

Professor of Nephrology, Newcastle University, Consultant Nephrologist Freeman Hospital and lead for National aHUS programme

Professor Sheerin will present results from the implementation of a National atypical haemolytic uraemic syndrome pathway

Professor Nicholas Selby

Associate Professor of Nephrology, University of Nottingham

Professor Selby will provide an update on UK Kidney Research Consortium AKI Clinical Study Group

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Dr Chris Laing, Consultant Nephrologist, University College London Hospitals NHS Foundation Trust and Royal Free London NHS Foundation Trust, Honorary Senior Lecturer, University College London and Chair, London AKI Network and

Dr Andrew Lewington, Consultant Nephrologist, Leeds Teaching Hospitals NHS Trust, Associate Professor, University of Leeds and Co-chair, UK Kidney Research Consortium AKI Clinical Study Group

Session one: Rapid communication

Dr Andrew Lewington and Dr Chris Laing

Update on UK Kidney Research Consortium AKI Clinical Study Group: Towards national collaboration in AKI research

Dr Nicholas Selby, Associate Professor of Nephrology, University of Nottingham

What is community acquired AKI?
Professor Aled Phillips, Professor of Nephrology and Clinical Director, Cardiff University and Cardiff and Vale NHS Trust Nephrology and Transplant Directorate
Utilising quality improvement methods to improve AKI outcomes in Manchester
Dr Lynne Sykes, Renal Speciality Registrar, ‘Q’ Fellow and QI Clinical Research Fellow in AKI, Salford Royal NHS Foundation Trust
The Scottish AKI improvement programme

Wendy Nimmo, Associate Improvement Advisor, Healthcare Improvement Advisor and Jennifer Pennycook, Clinical Lead Nurse, Scottish AKI Improvement Programme

Evaluation of a regional breakthrough series improvement collaborative in acute kidney injury in a secondary care setting
Dr Chris Laing
Panel discussion
Tea and coffee break

Session two: Special communication

Dr Laurie Tomlinson, Wellcome Trust Intermediate Fellow and Associate Professor, London School of Hygiene and Tropical Medicine and Honorary Consultant Nephrologist, Brighton and Sussex University Hospitals NHS Foundation Trust and Ms Elaine Davies, Director of Research Operations, Kidney Research UK

Keynote lecture: Novel therapies for acute kidney injury
Dr Mitch Rosner, Henry B Mulholland Professor of Medicine and Chair, Department of Medicine, University of Virginia, USA
Keynote lecture: AKI in children: Strategies for prevention and identification

Dr Stuart Goldstein, Director, Center for Acute Care Nephrology, Cincinnati Children’s Hospital Medical Center, USA

Lunch

Session three: Rapid communication

Dr Lynne Sykes and Dr Mitch Rosner

Tackling AKI: Results of a randomised, stepped-wedge evaluation of a multi-site AKI improvement intervention
Dr Nicholas Selby
Primary care interventions to improve outcomes in community - AKI
Dr Thomas Blakeman, Senior Academic GP, Division of Population Health, Health Services Research and Primary Care, University of Manchester
Atypical haemolytic uraemic syndrome: Insights from the implementation of a national service
Professor Neil Sheerin, Professor of Nephrology, Newcastle University, Consultant Nephrologist, Freeman Hospital and Lead for National aHUS Programme
Predicting AKI following emergency admission: Results of the RISK study
Professor Lui Forni, Professor of Intensive Care, University of Surrey and Consultant Intensivist, Royal Surrey County Hospital
Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: Results of a cohort study

Dr Laurie Tomlinson, Associate Professor, London School of Hygiene and Tropical Medicine, Honorary Consultant Nephrologist, Brighton and Sussex University Hospitals NHS Trust

Implementation and evaluation of a digitally-enabled care pathway for AKI: Results of the Google DeepMind - Royal Free London collaboration
Dr Chris Laing and Dr Ali Connell Clinical Research Fellow, University College London
Acute kidney injury in pregnancy: Improvements in recognition and treatment

Dr Kate Bramham, Consultant Nephrologist and Obstetric Medicine Specialist, King’s College Hospital and Senior Lecturer, King’s College Medical School

AKI in Sub-Saharan Africa: Challenges in resource limited settings

Dr Rhys Evans, Clinical lecturer in nephrology, University College London

Panel discussion
Tea and coffee break

Session four: Special communication

Dr Andy Lewington and Dr Chris Laing

The Shaun Summers Memorial Lecture: Insights into mechanisms of acute kidney injury
Professor Bruce Molitoris, Professor of Medicine and Director of Nephrology, Indiana University School of Medicine, USA
Concluding remarks
Close of meeting

Sponsors

Location

Royal Society of Medicine, 1 Wimpole St,, Marylebone, London, London, W1G 0AE, United Kingdom